Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Dexcom
MedTech
Dexcom wins FDA clearance for 15-day G7 CGM sensor
The new system, for people with Type 1 or Type 2 diabetes ages 18 and up, boosts wear time by 50% over the current G7 sensor.
Conor Hale
Apr 10, 2025 11:31am
Dexcom survey shows providers opt for tech over drugs in Type 2
Mar 19, 2025 12:20pm
Dexcom receives FDA warning letter over manufacturing issues
Mar 10, 2025 11:53am
Dexcom predicts 2025 gains, with Stelo pushing portfolio updates
Jan 14, 2025 10:45am
Abbott, Dexcom agree to 10-year truce over CGM patent litigation
Jan 2, 2025 11:43am
Fierce Medtech’s top 10 stories of 2024
Dec 23, 2024 11:45am
